{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:44:12Z","timestamp":1793105052874,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-056202"],"award-info":[{"award-number":["INV-056202"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-001763"],"award-info":[{"award-number":["INV-001763"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"crossref","award":["7200AA20C00017"],"award-info":[{"award-number":["7200AA20C00017"]}],"id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01162-5","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T14:49:35Z","timestamp":1747752575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Epitope specificity of antibody-mediated protection induced in mice by the malaria vaccine RTS,S\/AS01"],"prefix":"10.1038","volume":"10","author":[{"given":"Yevel","family":"Flores-Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice","family":"Salgado-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minah","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamika","family":"Mathis-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Locke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall S.","family":"MacGill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Re\u2019em","family":"Moskovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidel","family":"Zavala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"1162_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","volume":"386","author":"SCTP Rts","year":"2015","unstructured":"Rts, S. C. T. P. Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386, 31\u201345 (2015).","journal-title":"Lancet"},{"key":"1162_CR2","unstructured":"W. H. O. W. m. r. World Health Organization. World malaria report 2022. https:\/\/www.who.int\/teams\/global-malaria-programme"},{"key":"1162_CR3","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1093\/infdis\/171.6.1576","volume":"171","author":"DM Gordon","year":"1995","unstructured":"Gordon, D. M. et al. Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J. Infect. Dis. 171, 1576\u20131585 (1995).","journal-title":"J. Infect. Dis."},{"key":"1162_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(23)02511-4","volume":"403","author":"MS Datoo","year":"2024","unstructured":"Datoo, M. S. et al. Safety and efficacy of malaria vaccine candidate R21\/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial. Lancet 403, 533\u2013544 (2024).","journal-title":"Lancet"},{"key":"1162_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-3055-9","volume":"18","author":"Y Flores-Garcia","year":"2019","unstructured":"Flores-Garcia, Y. et al. Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stages. Malar. J. 18, 426 (2019).","journal-title":"Malar. J."},{"key":"1162_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00819-x","volume":"9","author":"E Locke","year":"2024","unstructured":"Locke, E. et al. Establishing RTS,S\/AS01 as a benchmark for comparison to next-generation malaria vaccines in a mouse model. NPJ Vaccines 9, 29 (2024).","journal-title":"NPJ Vaccines"},{"key":"1162_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/nm.4512","volume":"24","author":"NK Kisalu","year":"2018","unstructured":"Kisalu, N. K. et al. A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite. Nat. Med 24, 408\u2013416 (2018).","journal-title":"Nat. Med"},{"key":"1162_CR8","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.immuni.2020.08.014","volume":"53","author":"LT Wang","year":"2020","unstructured":"Wang, L. T. et al. A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver. Immunity 53, 733\u2013744.e738 (2020).","journal-title":"Immunity"},{"key":"1162_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41591-023-02659-z","volume":"30","author":"KL Williams","year":"2024","unstructured":"Williams, K. L. et al. A candidate antibody drug for prevention of malaria. Nat. Med 30, 117\u2013129 (2024).","journal-title":"Nat. Med"},{"key":"1162_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa2034031","volume":"385","author":"MR Gaudinski","year":"2021","unstructured":"Gaudinski, M. R. et al. A Monoclonal Antibody for Malaria Prevention. N. Engl. J. Med. 385, 803\u2013814 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1162_CR11","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1056\/NEJMoa2206966","volume":"387","author":"K Kayentao","year":"2022","unstructured":"Kayentao, K. et al. Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali. N. Engl. J. Med. 387, 1833\u20131842 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1162_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1056\/NEJMoa2203067","volume":"387","author":"RL Wu","year":"2022","unstructured":"Wu, R. L. et al. Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria. N. Engl. J. Med. 387, 397\u2013407 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1162_CR13","doi-asserted-by":"publisher","first-page":"e1010042","DOI":"10.1371\/journal.ppat.1010042","volume":"17","author":"Y Flores-Garcia","year":"2021","unstructured":"Flores-Garcia, Y. et al. The P. falciparum CSP repeat region contains three distinct epitopes required for protection by antibodies in vivo. PLoS Pathog. 17, e1010042 (2021).","journal-title":"PLoS Pathog."},{"key":"1162_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.molbiopara.2005.09.007","volume":"145","author":"CJ Janse","year":"2006","unstructured":"Janse, C. J. et al. High efficiency transfection of Plasmodium berghei facilitates novel selection procedures. Mol. Biochem Parasitol. 145, 60\u201370 (2006).","journal-title":"Mol. Biochem Parasitol."},{"key":"1162_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nprot.2006.53","volume":"1","author":"CJ Janse","year":"2006","unstructured":"Janse, C. J., Ramesar, J. & Waters, A. P. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei. Nat. Protoc. 1, 346\u2013356 (2006).","journal-title":"Nat. Protoc."},{"key":"1162_CR16","doi-asserted-by":"publisher","unstructured":"Espinosa, D. A. et al. Robust antibody and CD8(+) T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection. NPJ Vaccines 2, https:\/\/doi.org\/10.1038\/s41541-017-0011-y (2017).","DOI":"10.1038\/s41541-017-0011-y"},{"key":"1162_CR17","doi-asserted-by":"publisher","first-page":"E10438","DOI":"10.1073\/pnas.1715812114","volume":"114","author":"D Oyen","year":"2017","unstructured":"Oyen, D. et al. Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein. Proc. Natl Acad. Sci. USA 114, E10438\u2013E10445 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1162_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1303446","volume":"14","author":"JS Bolton","year":"2023","unstructured":"Bolton, J. S., MacGill, R. S., Locke, E., Regules, J. A. & Bergmann-Leitner, E. S. Novel antibody competition binding assay identifies distinct serological profiles associated with protection. Front Immunol. 14, 1303446 (2023).","journal-title":"Front Immunol."},{"key":"1162_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-020-03181-0","volume":"19","author":"R Raghunandan","year":"2020","unstructured":"Raghunandan, R. et al. Characterization of two in vivo challenge models to measure functional activity of monoclonal antibodies to Plasmodium falciparum circumsporozoite protein. Malar. J. 19, 113 (2020).","journal-title":"Malar. J."},{"key":"1162_CR20","doi-asserted-by":"publisher","first-page":"e1010409","DOI":"10.1371\/journal.ppat.1010409","volume":"18","author":"N Beutler","year":"2022","unstructured":"Beutler, N. et al. A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum. PLoS Pathog. 18, e1010409 (2022).","journal-title":"PLoS Pathog."},{"key":"1162_CR21","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.vaccine.2020.12.055","volume":"39","author":"S Chaudhury","year":"2021","unstructured":"Chaudhury, S. et al. Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the RTS,S malaria vaccine. Vaccine 39, 968\u2013975 (2021).","journal-title":"Vaccine"},{"key":"1162_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.20170869","volume":"215","author":"SW Scally","year":"2018","unstructured":"Scally, S. W. et al. Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection. J. Exp. Med. 215, 63\u201375 (2018).","journal-title":"J. Exp. Med."},{"key":"1162_CR23","doi-asserted-by":"publisher","first-page":"e1010133","DOI":"10.1371\/journal.ppat.1010133","volume":"17","author":"LT Wang","year":"2021","unstructured":"Wang, L. T. et al. Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein. PLoS Pathog. 17, e1010133 (2021).","journal-title":"PLoS Pathog."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01162-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01162-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01162-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T14:49:38Z","timestamp":1747752578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01162-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1162"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01162-5","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Author F.Z. serves as associate editor of this Journal and had no role in the peer review or decision to publish this manuscript. Author F.Z. declares no financial competing interest. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}